-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Sands Capital Management LLC Sells 43,916 Shares of HUTCHMED (China) Limited (NASDAQ:HCM)
Sands Capital Management LLC Sells 43,916 Shares of HUTCHMED (China) Limited (NASDAQ:HCM)
Sands Capital Management LLC trimmed its holdings in shares of HUTCHMED (China) Limited (NASDAQ:HCM – Get Rating) by 1.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,189,421 shares of the company's stock after selling 43,916 shares during the period. Sands Capital Management LLC owned about 2.42% of HUTCHMED worth $79,264,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the business. Capital International Investors raised its stake in HUTCHMED by 1.4% in the 4th quarter. Capital International Investors now owns 9,054,891 shares of the company's stock valued at $317,923,000 after acquiring an additional 128,422 shares during the period. BlackRock Inc. grew its holdings in HUTCHMED by 3.6% during the 1st quarter. BlackRock Inc. now owns 3,516,585 shares of the company's stock valued at $66,534,000 after buying an additional 123,396 shares in the last quarter. Schroder Investment Management Group grew its holdings in HUTCHMED by 2.4% during the 4th quarter. Schroder Investment Management Group now owns 3,102,043 shares of the company's stock valued at $21,764,000 after buying an additional 71,992 shares in the last quarter. Baillie Gifford & Co. grew its holdings in HUTCHMED by 0.5% during the 1st quarter. Baillie Gifford & Co. now owns 365,792 shares of the company's stock valued at $6,921,000 after buying an additional 1,724 shares in the last quarter. Finally, AIA Group Ltd grew its holdings in HUTCHMED by 10.0% during the 1st quarter. AIA Group Ltd now owns 356,640 shares of the company's stock valued at $6,748,000 after buying an additional 32,279 shares in the last quarter. 27.37% of the stock is currently owned by institutional investors.
Get HUTCHMED alerts:HUTCHMED Stock Up 5.4 %
Shares of NASDAQ HCM traded up $0.71 during midday trading on Friday, hitting $13.85. 2,176 shares of the company's stock were exchanged, compared to its average volume of 166,753. HUTCHMED has a 12-month low of $8.40 and a 12-month high of $41.07. The business's fifty day moving average price is $13.17 and its two-hundred day moving average price is $14.58.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on HCM. The Goldman Sachs Group lifted their target price on HUTCHMED from $14.00 to $16.00 and gave the company a "neutral" rating in a report on Tuesday, August 9th. StockNews.com raised HUTCHMED from a "sell" rating to a "hold" rating in a report on Monday, August 1st.About HUTCHMED
(Get Rating)
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors.
Featured Articles
- Get a free copy of the StockNews.com research report on HUTCHMED (HCM)
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- When Will the Hangover Finally Be Over for Seagate Technology?
Receive News & Ratings for HUTCHMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHMED and related companies with MarketBeat.com's FREE daily email newsletter.
Sands Capital Management LLC trimmed its holdings in shares of HUTCHMED (China) Limited (NASDAQ:HCM – Get Rating) by 1.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,189,421 shares of the company's stock after selling 43,916 shares during the period. Sands Capital Management LLC owned about 2.42% of HUTCHMED worth $79,264,000 at the end of the most recent reporting period.
根据纳斯达克向美国证券交易委员会(SEC)提交的最新文件,金沙资本管理有限公司在第一季度减持了和黄医药(中国)有限公司(Sequoia Capital(China)Limited)的股票,减持幅度为1.0%。该公司在此期间出售了43,916股后,持有该公司4,189,421股股票。截至最近一次报告期末,金沙资本管理有限公司持有和黄医药约2.42%的股份,价值79,264,000美元。
A number of other hedge funds also recently made changes to their positions in the business. Capital International Investors raised its stake in HUTCHMED by 1.4% in the 4th quarter. Capital International Investors now owns 9,054,891 shares of the company's stock valued at $317,923,000 after acquiring an additional 128,422 shares during the period. BlackRock Inc. grew its holdings in HUTCHMED by 3.6% during the 1st quarter. BlackRock Inc. now owns 3,516,585 shares of the company's stock valued at $66,534,000 after buying an additional 123,396 shares in the last quarter. Schroder Investment Management Group grew its holdings in HUTCHMED by 2.4% during the 4th quarter. Schroder Investment Management Group now owns 3,102,043 shares of the company's stock valued at $21,764,000 after buying an additional 71,992 shares in the last quarter. Baillie Gifford & Co. grew its holdings in HUTCHMED by 0.5% during the 1st quarter. Baillie Gifford & Co. now owns 365,792 shares of the company's stock valued at $6,921,000 after buying an additional 1,724 shares in the last quarter. Finally, AIA Group Ltd grew its holdings in HUTCHMED by 10.0% during the 1st quarter. AIA Group Ltd now owns 356,640 shares of the company's stock valued at $6,748,000 after buying an additional 32,279 shares in the last quarter. 27.37% of the stock is currently owned by institutional investors.
其他一些对冲基金最近也调整了它们在该业务中的头寸。资本国际投资者在第四季度增持和黄医药股份1.4%.Capital International Investors在此期间增持了128,422股,目前持有该公司9,054,891股股票,价值317,923,000美元。贝莱德股份有限公司在第一季度增持了3.6%的和黄医药股份。贝莱德股份有限公司现在持有该公司3,516,585股股票,价值66,534,000美元,该公司在上个季度又购买了123,396股。施罗德投资管理集团在第四季度增持了和黄医药的股份2.4%。施罗德投资管理集团目前持有该公司3,102,043股股票,价值21,764,000美元,上一季度又购买了71,992股。第一季度,百利吉福德公司对和黄医药的持股增加了0.5%。Baillie Gifford&Co.现在持有365,792股该公司股票,价值6,921,000美元,上个季度又购买了1,724股。最后,友邦保险股份有限公司在第一季度增持了10.0%的和黄医药股份。友邦保险股份有限公司在上个季度额外购买了32,279股后,现在拥有356,640股该公司股票,价值6,748,000美元。该公司27.37%的股票目前由机构投资者持有。
HUTCHMED Stock Up 5.4 %
和黄医药股价上涨5.4%
Shares of NASDAQ HCM traded up $0.71 during midday trading on Friday, hitting $13.85. 2,176 shares of the company's stock were exchanged, compared to its average volume of 166,753. HUTCHMED has a 12-month low of $8.40 and a 12-month high of $41.07. The business's fifty day moving average price is $13.17 and its two-hundred day moving average price is $14.58.
上周五午盘,纳斯达克点评股价上涨0.71美元,至13.85美元。该公司股票成交量为2,176股,而其平均成交量为166,753股。和黄医药的12个月低点为8.4美元,12个月高位为41.07美元。该业务的50日移动均线价格为13.17美元,200日移动均线价格为14.58美元。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
About HUTCHMED
关于和黄医药
(Get Rating)
(获取评级)
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors.
和黄医药(中国)有限公司在香港和国际上发现、开发癌症和免疫疾病的靶向疗法和免疫疗法,并将其商业化。它在肿瘤学/免疫学和其他风险投资领域开展业务。该公司开发Savolitinib,一种治疗非小细胞肺癌(NSCLC)、乳头状细胞癌和肾癌、结直肠癌(CRC)和胃癌(GC)的抑制剂;以及Fruquintinib,一种治疗CRC、乳腺癌、GC、子宫内膜癌(EMC)、非小细胞肺癌、肝细胞癌以及胃肠道和实体肿瘤的抑制剂。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on HUTCHMED (HCM)
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- When Will the Hangover Finally Be Over for Seagate Technology?
- 免费获取斯托克新闻网关于和黄医药的研究报告
- 为网络安全股创纪录的季度做准备
- 汽车市场正在缓慢复苏,这些股票可能表现优异
- DocuSign是否即将发生重大逆转?
- 石油和天然气股票:投资可再生能源的安全途径
- 希捷科技的宿醉何时才能结束?
Receive News & Ratings for HUTCHMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHMED and related companies with MarketBeat.com's FREE daily email newsletter.
接受《和黄医药日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对和黄医药及相关公司的最新新闻和分析师评级的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧